Skip to main content
. 2021 Oct 2;13(10):1981. doi: 10.3390/v13101981

Figure 9.

Figure 9

Inhibitors of SARS-CoV-2 Mpro in clinical trials (A) and inhibitors of the Mpro precursor (B).